Peritoneal Dialysis Patients Clinical Trial
Official title:
Exploring The Therapeutic Benefits Of Oral Protein Supplementation In Malnourished Dialysis Patients
Verified date | December 2017 |
Source | National University of Malaysia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The dialysis population has a strikingly high incidence of mortality. The life expectancy of chronic dialysis patients is 20 years less than that of the general population. Approximately 50% of individuals with end stage renal disease (ESRD) die from a cardiovascular (CV) cause with mortality being 15 to 30 times higher than the age-adjusted CV mortality in the general population. There is also a steady increase of patients with diabetes and the older age groups coming into dialysis. The treatment of patients with ESRD aims at prolonging life, achieving good nutritional status and promoting the best possible functioning and quality of life (QOL). Several factors that are beyond adequacy of dialysis predict high mortality in ESRD patients. Associated co-morbidities and malnutrition factors are independently associated and the combined presence of both malnutrition and co-morbidities manifest the worst survival.Therefore this study investigates the efficacy of protein supplementation in improving health status and quality of life among peritoneal dialysis (PD) patients. This research will also generate basic data about significant health markers critical to the health status of PD patients.
Status | Completed |
Enrollment | 74 |
Est. completion date | August 31, 2013 |
Est. primary completion date | August 31, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Aged > 18 years old and =70 years old - Undergone dialysis at least for 6 months. - Categorised as malnourished based on BMI <24 kg/m² and serum albumin =40 g/L criteria - No incidence of hospitalisation for past 3 months, free of infection/sepsis and have not undergone surgery for past 6 months. Exclusion Criteria: - Patients with high inflammatory diseases, malignancy, cancer - Vegetarian patients |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National University of Malaysia |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum albumin | Biochemistry marker that indicates nutritional status | Change from baseline serum albumin at 6 months of the study | |
Primary | Body mass index (BMI) | Index that depicts if one's current weight is ideal for their height | Change from BMI at 6 months of the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03773029 -
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT00433849 -
Clinical Study of R744 to Peritoneal Dialysis Patients
|
Phase 3 |